Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy
172,00 €*
Sofort verfügbar, Lieferzeit: 1-3 Tage
Produktnummer:
9780128164358
Tyrosine Kinase Inhibitors as Sensitizing Agents for Chemotherapy, the fourth volume in the Cancer Sensitizing Agents for Chemotherapy Series, focuses on strategic combination therapies that involve a variety of tyrosine kinase inhibitors working together to overcome multi-drug resistance in cancer cells. The book discusses several tyrosine kinase inhibitors that have been used as sensitizing agents, such as EGFR, BCR-ABL, ALK and BRAF. In each chapter, readers will find comprehensive knowledge on the inhibitor and its action, including its biochemical, genetic, and molecular mechanisms' emphases. This book is a valuable source for oncologists, cancer researchers and those interested in applying new sensitizing agents to their research in clinical practice and in trials.
| EAN: | 9780128164358 |
|---|---|
| Sprache: | Englisch |
| Produktart: | Gebunden |
| Herausgeber: | Bonavida, Benjamin Chen, Zhe-Sheng (Jason) Yang, Dong-Hua |
| Verlag: | Academic Press Elsevier Science & Technology |
| Schlagworte: | Inhibitor Medizin |
| Größe: | 235 × 191 × 234 |
| Gewicht: | 770 g |
